Global Signal Transduction Inhibitors Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1345

Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues.
Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibitors market.
In 2018, the global Signal Transduction Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Signal Transduction Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Signal Transduction Inhibitors development in United States, Europe and China.

The key players covered in this study
Bristol-Myers Squibb
Roche
AstraZeneca
GSK
Novartis
Amgen
Pfizer
...

Market segment by Type, the product can be split into
Dasatinib
Erlotinib
Gefitinib
Imatinib
Lapatinib
Nilotinib
Pazopanib
Sorafenib
Sunitinib

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Signal Transduction Inhibitors status, future forecast, growth opportunity, key market and key players.
To present the Signal Transduction Inhibitors development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Signal Transduction Inhibitors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Signal Transduction Inhibitors Market Size Growth Rate by Type (2014-2025)
1.4.2 Dasatinib
1.4.3 Erlotinib
1.4.4 Gefitinib
1.4.5 Imatinib
1.4.6 Lapatinib
1.4.7 Nilotinib
1.4.8 Pazopanib
1.4.9 Sorafenib
1.4.10 Sunitinib
1.5 Market by Application
1.5.1 Global Signal Transduction Inhibitors Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Signal Transduction Inhibitors Market Size
2.2 Signal Transduction Inhibitors Growth Trends by Regions
2.2.1 Signal Transduction Inhibitors Market Size by Regions (2014-2025)
2.2.2 Signal Transduction Inhibitors Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Signal Transduction Inhibitors Market Size by Manufacturers
3.1.1 Global Signal Transduction Inhibitors Revenue by Manufacturers (2014-2019)
3.1.2 Global Signal Transduction Inhibitors Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Signal Transduction Inhibitors Market Concentration Ratio (CR5 and HHI)
3.2 Signal Transduction Inhibitors Key Players Head office and Area Served
3.3 Key Players Signal Transduction Inhibitors Product/Solution/Service
3.4 Date of Enter into Signal Transduction Inhibitors Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Signal Transduction Inhibitors Market Size by Type (2014-2019)
4.2 Global Signal Transduction Inhibitors Market Size by Application (2014-2019)

5 United States
5.1 United States Signal Transduction Inhibitors Market Size (2014-2019)
5.2 Signal Transduction Inhibitors Key Players in United States
5.3 United States Signal Transduction Inhibitors Market Size by Type
5.4 United States Signal Transduction Inhibitors Market Size by Application

6 Europe
6.1 Europe Signal Transduction Inhibitors Market Size (2014-2019)
6.2 Signal Transduction Inhibitors Key Players in Europe
6.3 Europe Signal Transduction Inhibitors Market Size by Type
6.4 Europe Signal Transduction Inhibitors Market Size by Application

7 China
7.1 China Signal Transduction Inhibitors Market Size (2014-2019)
7.2 Signal Transduction Inhibitors Key Players in China
7.3 China Signal Transduction Inhibitors Market Size by Type
7.4 China Signal Transduction Inhibitors Market Size by Application

8 Japan
8.1 Japan Signal Transduction Inhibitors Market Size (2014-2019)
8.2 Signal Transduction Inhibitors Key Players in Japan
8.3 Japan Signal Transduction Inhibitors Market Size by Type
8.4 Japan Signal Transduction Inhibitors Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Signal Transduction Inhibitors Market Size (2014-2019)
9.2 Signal Transduction Inhibitors Key Players in Southeast Asia
9.3 Southeast Asia Signal Transduction Inhibitors Market Size by Type
9.4 Southeast Asia Signal Transduction Inhibitors Market Size by Application

10 India
10.1 India Signal Transduction Inhibitors Market Size (2014-2019)
10.2 Signal Transduction Inhibitors Key Players in India
10.3 India Signal Transduction Inhibitors Market Size by Type
10.4 India Signal Transduction Inhibitors Market Size by Application

11 Central & South America
11.1 Central & South America Signal Transduction Inhibitors Market Size (2014-2019)
11.2 Signal Transduction Inhibitors Key Players in Central & South America
11.3 Central & South America Signal Transduction Inhibitors Market Size by Type
11.4 Central & South America Signal Transduction Inhibitors Market Size by Application

12 International Players Profiles
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Signal Transduction Inhibitors Introduction
12.1.4 Bristol-Myers Squibb Revenue in Signal Transduction Inhibitors Business (2014-2019)
12.1.5 Bristol-Myers Squibb Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Signal Transduction Inhibitors Introduction
12.2.4 Roche Revenue in Signal Transduction Inhibitors Business (2014-2019)
12.2.5 Roche Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Company Details
12.3.2 Company Description and Business Overview
12.3.3 Signal Transduction Inhibitors Introduction
12.3.4 AstraZeneca Revenue in Signal Transduction Inhibitors Business (2014-2019)
12.3.5 AstraZeneca Recent Development
12.4 GSK
12.4.1 GSK Company Details
12.4.2 Company Description and Business Overview
12.4.3 Signal Transduction Inhibitors Introduction
12.4.4 GSK Revenue in Signal Transduction Inhibitors Business (2014-2019)
12.4.5 GSK Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Signal Transduction Inhibitors Introduction
12.5.4 Novartis Revenue in Signal Transduction Inhibitors Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Amgen
12.6.1 Amgen Company Details
12.6.2 Company Description and Business Overview
12.6.3 Signal Transduction Inhibitors Introduction
12.6.4 Amgen Revenue in Signal Transduction Inhibitors Business (2014-2019)
12.6.5 Amgen Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Signal Transduction Inhibitors Introduction
12.7.4 Pfizer Revenue in Signal Transduction Inhibitors Business (2014-2019)
12.7.5 Pfizer Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details